Crowdonomics
WatchlistPortfolio
THE BIG GAME

Reg CF · Revenue Share · Jun 2023

ClosedReg CFRevenue Share
via WeFunderView campaign
Raised
$45K / $350K max
13% of ceiling · target hit day 5
Investors
—
—
Valuation
—
—

Raised over time

Cumulative raisedInvestors
$57K$28K$0
1680
Jun 9, 2023 · openedApr 30, 2024 · last reading
Target ($50K) hit — Jun 14, 2023, day 5Deadline Apr 30, 2025 — 365 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2021–FY2022 · hover for source
$0
FY2021
$0
FY2022
RevenueNet income
Metric
FY2021 reviewed*
FY2022 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
$0
Taxes paid
$0
$0
Balance sheet
Cash
$0
$6,000
Accounts receivable
$0
$0
Total assets
$0
$6,000
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Apr 1, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Perks

125% of principal + 30% of net profits

Offering details

Target$50,000
Max$350,000
Min investment$500
OpenedJun 9, 2023
DeadlineApr 30, 2025
ClosedApr 29, 2024
Days active325

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-23-000635

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.